Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Denali Therapeutics (DNLI) Interest & Investment Income: 2022-2024

Historic Interest & Investment Income for Denali Therapeutics (DNLI) over the last 3 years, with Dec 2024 value amounting to $64.6 million.

  • Denali Therapeutics' Interest & Investment Income rose 15.48% to $15.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $64.6 million, marking a year-over-year increase of 25.49%. This contributed to the annual value of $64.6 million for FY2024, which is 25.49% up from last year.
  • As of FY2024, Denali Therapeutics' Interest & Investment Income stood at $64.6 million, which was up 25.49% from $51.5 million recorded in FY2023.
  • In the past 5 years, Denali Therapeutics' Interest & Investment Income ranged from a high of $64.6 million in FY2024 and a low of $14.8 million during FY2022.
  • In the last 3 years, Denali Therapeutics' Interest & Investment Income had a median value of $51.5 million in 2023 and averaged $43.6 million.
  • Data for Denali Therapeutics' Interest & Investment Income shows a peak YoY skyrocketed of 248.62% (in 2023) over the last 5 years.
  • Over the past 3 years, Denali Therapeutics' Interest & Investment Income (Yearly) stood at $14.8 million in 2022, then soared by 248.62% to $51.5 million in 2023, then rose by 25.49% to $64.6 million in 2024.